| 000 | 00642nam a2200193Ia 4500 | ||
|---|---|---|---|
| 008 | 241218s9999 xx 000 0 und d | ||
| 020 | _a9780420084726 | ||
| 040 | _aJamia Hamdard | ||
| 041 | _aEnglish | ||
| 082 |
_a615.19 _bP76P |
||
| 245 | 0 |
_aPreclinical drug development _cedited by Mark C. Rogge, David R. Taft. |
|
| 260 |
_aNew York _bInforma health care _cc2010. |
||
| 300 | _aviii, 348p: ill; 22 cm | ||
| 440 | _a(Drugs and the pharmaceutical sciences .187). | ||
| 650 |
_aDrug Development _bDrug Evaluation, Preclinical - methods _cDrug Industry - methods. |
||
| 700 | _aRogge, Mark C. | ||
| 700 | _aTaft, David R. | ||
| 942 | _cBK | ||
| 999 |
_c62401 _d62401 |
||